About
David Anderson joined Ampersand in 2010. He previously spent six years at Covington Associates, a specialty investment bank focused on middle-market healthcare M&A, and five years before that as a consultant at Boston Healthcare Associates. He holds a B.Sc. from the University of Aberdeen, a Ph.D. in Immunology from the University of Sheffield, and an M.B.A. from Babson College.
Invests in
BiotechHealthtech
Investments
Board seats
AnaBiosArrantaBioAvid BioservicesBioClinicaBrammerBioCelleroGannet BioChemGenezenStagebioVibalogics
Per the firm's website.
Colleagues at Ampersand
Aditya V. Goel
Associate at Ampersand
Benoit P. Bouche
Operating Partner at Ampersand
Cole S. Aldrich
Senior Associate at Ampersand
Dean D. Schauer
Operating Partner at Ampersand
Elias J. Laimboeck
Senior Associate at Ampersand
Emanuele M. Delfino
Associate at Ampersand
Eric B. Lev
General Partner at Ampersand
Frank R. Witney
Operating Partner at Ampersand
Frequently asked questions
- Who is David Q. Anderson?
- David Anderson joined Ampersand in 2010. He previously spent six years at Covington Associates, a specialty investment bank focused on middle-market healthcare M&A, and five years before that as a consultant at Boston Healthcare Associates. He holds a B.Sc. from the University of Aberdeen, a Ph.D. in Immunology from the University of Sheffield, and an M.B.A. from Babson College.
- Where does David Q. Anderson work?
- David Q. Anderson is General Partner at Ampersand.
- What does David Q. Anderson invest in?
- David Q. Anderson invests in Biotech, Healthtech.
- What boards does David Q. Anderson sit on?
- David Q. Anderson holds tracked board seats at AnaBios, ArrantaBio, Avid Bioservices, BioClinica, BrammerBio, Cellero, Gannet BioChem, Genezen, Stagebio, Vibalogics.